Publications of I. A. Nakchbandi

Altrock, E.; Sottile, J.; Nakchbandi, I. A.: INHBITION OF MATRIX ACCUMULATION USING SMALL PEPTIDES REVERSES LIVER FIRBOSIS. In Journal of Hepatology, 64, p. S706 - S706. EASL International Liver Congress, Barcelona, SPAIN, April 13, 2016 - April 17, 2016. Elsevier, Amsterdam (2016)

Kawelke, N.; Nakchbandi, I.: Beta1 integrin on osteoblast progenitors affects bone formation and mineralization. In Bone, 50 (Suppl. 1), pp. S41 - S42. ELSEVIER SCIENCE INC, NEW YORK (2012)

Sens, C.; Kawelke, N.; Nakchbandi, I.: A fibronectin isoform containing the extra domain A (EDA) increases osteoblast differentiation and function. In Bone, 50 (Suppl. 1), pp. S74 - S75. ELSEVIER SCIENCE INC, NEW YORK (2012)

Sens, C.; von Au, A.; Kawelke, N.; Nakchbandi, I.: O-glycosylation in the variable region of fibronectin modulates osteoblast function in vitro and in vivo. In Bone, 50 (Suppl. 1), p. S74 - S74. ELSEVIER SCIENCE INC, NEW YORK (2012)

von Au, A.; Vasel, M.; Kraft, S.; Cecchini, M. G.; Wetterwald, A.; Nakchbandi, I.: Circulating fibronectin increases tumor growth and fibronectin content of tumors correlates with survival. In Bone, 50 (Suppl. 1), pp. S50 - S51. ELSEVIER SCIENCE INC, NEW YORK (2012)

Kawelke, N.; Kraft, S.; Vasel, M.; Nakchbandi, I. A.: Beta1 integrin expression in osteoblast progenitors is required for bone formation. In Bone, 48 (Suppl. 2), p. S118 - S118. ELSEVIER SCIENCE INC, NEW YORK (2011)

von Au, A.; Vasel, M.; Glueer, C. C.; Tiwari, S.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating fibronectin is required for blood vessel formation and tumor growth. In Bone, 48 (Suppl. 2), p. S251 - S251. ELSEVIER SCIENCE INC, NEW YORK (2011)